| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.14 | 0.05 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.059 | 0.05 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.092 | 0.05 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.05 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.06 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.064 | 0.06 |